Neurological diseases and RNA-directed gene regulation: Prospects for new diagnostics and therapy

Expert Review of Molecular Diagnostics

Volumn 3, Issue 3, 2003, Pages 269-274

  Broude, Natalia E ^a,b   Cantor, Charles R ^c  

^a Boston University   (United States)

^b BOSTON UNIVERSITY   (United States)

^c SEQUENOM INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

DMPK GENE; EDITORIAL; FUTUROLOGY; GENE EXPRESSION REGULATION; GENE LOCATION; GENE MUTATION; GENE THERAPY; HUMAN; MOLECULAR BIOLOGY; MYOTONIC DYSTROPHY; NERVE DEGENERATION; NEUROLOGIC DISEASE; PATHOLOGICAL ANATOMY; REGULATOR GENE; RNA ANALYSIS; RNA DIRECTED GENE REGULATION; TRINUCLEOTIDE REPEAT;

ALTERNATIVE SPLICING; GENE EXPRESSION REGULATION; GENES, DOMINANT; GENES, RECESSIVE; HUMANS; MODELS, GENETIC; MUSCLES; MUTATION; NERVOUS SYSTEM DISEASES; NEURONS; RIBONUCLEOPROTEINS; RNA; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0037611037     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.3.3.269     Document Type: Editorial

References (43)

1. Fu YH, Kuhl DP, Pizzud A et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67, 1047-1058 (1991).
2. Kremer EJ, Pritchard M, Lynch M et al. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252, 1711-1714 (1991).
3. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79 (1991).
4. Cummings CJ, Zoghbi HY. Trinucleotide repeats: mechanisms and pathophysiology. Ann. Rev. Genomics Hum. Genet. 1, 281-328 (2000).
5. Fischbeck KH. Polyglutamine expansion neurodegenerative disease. Brain Res. Bull. 56, 161-163 (2001).
6. Paulson HL, Bonini NM, Roth KA. Polyglutamine disease and neuronal cell death. Proc. Natl Acad. Sci. USA 97, 12957-12958 (2000).
7. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Ann. Rev. Neurosci. 23, 217-47 (2000).
8. Zoghbi HY, Botas J. Mouse and fly models of neurodegeneration. Trends Genet. 18, 463-471 (2002).
9. Davies SW, Turmaine M, Cozens BA et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548 (1997).
10. DiFiglia M, Sapp E, Chase KO et al. Aggregation of huntingtin in neuronal intranudear inclusions and dystrophic neurites in brain. Science 277, 1990-1993 (1997).
11. Nakamoto M, Nakano S, Kawashima S et al. Unequal crossing-over in unique PABP2 mutations in Japanese patients: a possible cause of oculopharyngeal muscular dystrophy. Arch. Neurol. 59, 474-477 (2002).
12. Larkin K, Fardaei M. Myotonic dystrophy - a multigene disorder. Brain Res. Bull. 56, 389-395 (2001).
13. Wang J, Pegoraro E, Menegazzo E et al. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 4, 599-606 (1995).
14. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. Foci of trinudeotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128, 995-1002 (1995).
15. Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA 94, 7388-7393 (1997).
16. Khajavi M, Tari AM, Patel NB et al. 'Mitotic drive' of expanded CTG repeats in myotonic dystrophy Type 1 (DM1). Hum. Mol. Genet. 10, 855-863 (2001).
17. Timchenko NA, Iakova P, Cai ZJ, Smith JR, Timchenko LT. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol. Cell Biol. 21, 6927-6938 (2001).
18. Caskey CT, Swanson MS, Timchenko LT. Myotonic dystrophy: discussion of molecular mechanism. Cold Spring Harb. Symp. Quant. Biol. 61, 607-614 (1996).
19. Timchenko LT, Miller JW, Timchenko NA et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy Nucleic Acids Res. 24, 4407-4414 (1996).
20. Junghans RP, Ebralidze A, Tiwari B. Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy? A new hypothesis of long-range cis autosomal inactivation. Neurogenetics 3, 59-67 (2001).
21. Napierala M, Krzyosiak WJ. CUG repeats present in myotonin kinase RNA form metastable 'slippery' hairpins. J. Biol. Chem. 272, 31079-31085 (1997).
22. Miller JW, Urbinati CR, Teng-Umnuay P et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439-4448 (2000).
23. Mankodi A, Logigian E, Callahan L et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769-1773 (2000).
24. Amack JD, Reagan SR, Mahadevan MS. Mutant DMPK 3′-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J. Cell Biol. 159, 419-429 (2002).
25. Ranum LP, Day JW. Dominantly inherited, non-coding microsatellite expansion disorders. Curr. Opin. Genet. Dev. 12, 266-271 (2002).
26. Ranum LP, Day JW. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy Type 1 and Type 2. Curr. Neurol. Neurosci. Rep. 2, 465-470 (2002).
27. Tiscornia G, Mahadevan MS. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol. Cells 5, 959-967 (2000).
28. Mankodi A, Takahashi MP, Jiang H et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cells 10, 35-44 (2002).
29. Charlet BN, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the musde-specific chloride channel in Type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cells 10, 45-53 (2002).
30. Fardaei M, Rogers MT, Thorpe HM et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 11, 805-814 (2002).
31. Tapscott SJ, Thornton CA. Reconstructing myotonic dystrophy. Science 293, 816-817 (2001).
32. Tapscott SJ. Deconstructing myotonic dystrophy. Science 289, 1701-1702 (2000).
33. Galvao R, Mendes-Soares L, Camara J, Jaco I, Carmo-Fonseca M. Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis. Brain Res. Bull. 56, 191-201 (2001).
34. Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66 (1998).
35. Nemes JP, Benzow KA, Moseley ML, Ranum LP, Koob MD. The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1). Hum. Mol. Genet. 9, 1543-1551 (2000).
36. Holmes SE, O'Hearn EE, McInnis MG et al. Expansion of a novel CAG trinudeotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nature Genet. 23, 391-392 (1999).
37. Matsuura T, Yamagata T, Burgess DL et al. Large expansion of the ATTCT pentanudeotide repeat in spinocerebellar ataxia Type 10. Nature Genet. 26, 191-194 (2000).
38. Margolis RL, O'Hearn E, Rosenblatt A et al. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion. Ann. Neurol. 50, 373-380 (2001).
39. Chai Y, Shao J, Miller VM, Williams A, Paulson HL. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc. Natl Acad. Sci. USA 99, 9310-9315 (2002).
40. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408, 101-106 (2000).
41. Caplen NJ, Taylor JP, Statham VS, Tanaka F, Fire A, Morgan RA. Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum. Mol. Genet. 11, 175-184 (2002).
42. Caudy AA, Myers M, Hannon GJ, Hammond SM. Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev. 16, 2491-2496 (2002).
43. Ishizuka A, Siomi MC, Siomi HA. Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins. Genes Dev. 16, 2497-2508 (2002).